Question 1

Which of these steps is NOT part of the transplant adverse events investigation process?

Accepted Answer

A)  All of the tissues that originated from that donor must be investigated. 
B)  Communications between tissue bank and supplier to initiate a recall. 
C)  Additional tissue is tracked down to prevent transmission of disease to other recipients. 
D)  Vendor validation of transport containers 
A)  All of the tissues that originated from that donor must be investigated. 
B)  Communications between tissue bank and supplier to initiate a recall. 
C)  Additional tissue is tracked down to prevent transmission of disease to other recipients. 
D)  Vendor validation of transport containers

Question 2

Who among the following is NOT usually part of the committee that selects tissue vendors?

Accepted Answer

A)  Blood bank staff technologist 
B)  Head surgeon of transplant staff 
C)  Laboratory/ tissue bank medical director 
D)  Would care physician using tissues 
A)  Blood bank staff technologist 
B)  Head surgeon of transplant staff 
C)  Laboratory/ tissue bank medical director 
D)  Would care physician using tissues

Question 3

Donors for cornea transplants must be tested for all but which of the following diseases prior to transplant?

Accepted Answer

A)  HIV-1 and -2 
B)  Hepatitis B 
C)  Hepatitis C 
D)  Chlamydia trachomatis 
A)  HIV-1 and -2 
B)  Hepatitis B 
C)  Hepatitis C 
D)  Chlamydia trachomatis

Question 4

What aspect of tissue banking is especially important during product recalls?

Accepted Answer

A)  Accreditation of the tissue bank 
B)  Qualifications of the medical director 
C)  Traceability of the tissue to donor 
D)  Vendor validation 
A)  Accreditation of the tissue bank 
B)  Qualifications of the medical director 
C)  Traceability of the tissue to donor 
D)  Vendor validation

Question 5

The first step in qualifying any vendor is to:

Accepted Answer

A)  determine the number of FDA recalls by this vendor. 
B)  have your medical director establish communication with the vendor's medical director. 
C)  order a sample tissue on which to perform quality checks. 
D)  verify the supplier's FDA registration. 
A)  determine the number of FDA recalls by this vendor. 
B)  have your medical director establish communication with the vendor's medical director. 
C)  order a sample tissue on which to perform quality checks. 
D)  verify the supplier's FDA registration.

Question 6

How is an adverse transplant event defined?

Accepted Answer

A)  A negative change in the tissue recipient 
B)  The patient has a reaction to tissue implant 
C)  There is an unexpected outcome after tissue implant 
D)  All of these 
A)  A negative change in the tissue recipient 
B)  The patient has a reaction to tissue implant 
C)  There is an unexpected outcome after tissue implant 
D)  All of these

Question 7

Records of tissue must be kept at least after expiration.

Accepted Answer

A)  2 years 
B)  5 years 
C)  10 years 
D)  indefinitely 
A)  2 years 
B)  5 years 
C)  10 years 
D)  indefinitely

Question 8

If your facility is a member of and accredited by the Eye Bank Associates of America, there is no need to be monitored by the FDA.

Accepted Answer

A) True 
 B)False

Which of these steps is NOT part of the transplant adverse events investigation process?

Who among the following is NOT usually part of the committee that selects tissue vendors?

Donors for cornea transplants must be tested for all but which of the following diseases prior to transplant?

What aspect of tissue banking is especially important during product recalls?

The first step in qualifying any vendor is to:

How is an adverse transplant event defined?

Records of tissue must be kept at least after expiration.

If your facility is a member of and accredited by the Eye Bank Associates of America, there is no need to be monitored by the FDA.

Red Blood Cells and Platelet Preservation: Historical Perspectives and Current Trends

Basic Genetics

Fundamentals of Immunology

Concepts in Molecular Biology

The Antiglobulin Test

The Abo Blood Group System

The Rh Blood Group System

Blood Group Terminology and Common Blood Groups

Uncommon Blood Groups

Detection and Identification of Antibodies

Pre-Transfusion Testing

Blood Bank Technologies and Automation

Donor Selection

Transfusion-Transmitted Diseases

Component Preparation

Transfusion Therapy

Adverse Effects of Blood Transfusion

Apheresis

Cellular Therapy in the Transplant Setting

Hemolytic Disease of the Fetus and Newborn

Autoimmune Hemolytic Anemias

The Hla System

Relationship Testing

Quality Management

Patient Blood Management

Transfusion Safety and Federal Regulatory Requirements

Laboratory Information Systems in the Blood Bank

Medicolegal and Ethical Aspects of Providing Blood Collection and Transfusion Services

Filters

Exam 22: Tissue Banking As Part of the Transfusion Service

Which of these steps is NOT part of the transplant adverse events investigation process?

Who among the following is NOT usually part of the committee that selects tissue vendors?

Donors for cornea transplants must be tested for all but which of the following diseases prior to transplant?

What aspect of tissue banking is especially important during product recalls?

The first step in qualifying any vendor is to:

How is an adverse transplant event defined?

Records of tissue must be kept at least after expiration.

If your facility is a member of and accredited by the Eye Bank Associates of America, there is no need to be monitored by the FDA.

Red Blood Cells and Platelet Preservation: Historical Perspectives and Current Trends

Basic Genetics

Fundamentals of Immunology

Concepts in Molecular Biology

The Antiglobulin Test

The Abo Blood Group System

The Rh Blood Group System

Blood Group Terminology and Common Blood Groups

Uncommon Blood Groups

Detection and Identification of Antibodies

Pre-Transfusion Testing

Blood Bank Technologies and Automation

Donor Selection

Transfusion-Transmitted Diseases

Component Preparation

Transfusion Therapy

Adverse Effects of Blood Transfusion

Apheresis

Cellular Therapy in the Transplant Setting

Hemolytic Disease of the Fetus and Newborn

Autoimmune Hemolytic Anemias

The Hla System

Relationship Testing

Quality Management

Patient Blood Management

Transfusion Safety and Federal Regulatory Requirements

Laboratory Information Systems in the Blood Bank

Medicolegal and Ethical Aspects of Providing Blood Collection and Transfusion Services

Filters